메뉴 건너뛰기




Volumn 42, Issue 5, 2017, Pages 519-529

Comparison between anti-VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis

Author keywords

anti VEGF; dexamethasone; laser photocoagulation; retinal vein occlusion; triamcinolone

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; CORTICOSTEROID; DEXAMETHASONE; RANIBIZUMAB; TRIAMCINOLONE; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR; GLUCOCORTICOID; VASCULOTROPIN A;

EID: 85021264746     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12551     Document Type: Review
Times cited : (35)

References (40)
  • 1
    • 0028204368 scopus 로고
    • Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics
    • Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994;117:429-441.
    • (1994) Am J Ophthalmol , vol.117 , pp. 429-441
    • Hayreh, S.S.1    Zimmerman, M.B.2    Podhajsky, P.3
  • 2
    • 84961266779 scopus 로고    scopus 로고
    • Retinal vein occlusion: an interdisciplinary approach
    • Hatz K, Martinez M. Retinal vein occlusion: an interdisciplinary approach. Ther Umsch. 2016;73:85-89.
    • (2016) Ther Umsch , vol.73 , pp. 85-89
    • Hatz, K.1    Martinez, M.2
  • 3
    • 75149172639 scopus 로고    scopus 로고
    • International eye disease consortium: the prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia
    • Rogers S, McIntosh RL, Cheung N, et al. International eye disease consortium: the prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117:313-319.
    • (2010) Ophthalmology , vol.117 , pp. 313-319
    • Rogers, S.1    McIntosh, R.L.2    Cheung, N.3
  • 4
    • 78649415975 scopus 로고    scopus 로고
    • Retinal-vein occlusion
    • Wong TY, Scott IU. Retinal-vein occlusion. N Engl J Med. 2010;363:2135-2144.
    • (2010) N Engl J Med , vol.363 , pp. 2135-2144
    • Wong, T.Y.1    Scott, I.U.2
  • 5
    • 0022540373 scopus 로고
    • Argon laser photocoagulation for macular edema in branch vein occlusion
    • Finkelstein D. Argon laser photocoagulation for macular edema in branch vein occlusion. Ophthalmology. 1986;93:975-977.
    • (1986) Ophthalmology , vol.93 , pp. 975-977
    • Finkelstein, D.1
  • 7
    • 80051776549 scopus 로고    scopus 로고
    • The burden of disease of retinal vein occlusion: review of the literature
    • Laouri M, Chen E, Looman M, et al. The burden of disease of retinal vein occlusion: review of the literature. Eye. 2011;25:981-988.
    • (2011) Eye , vol.25 , pp. 981-988
    • Laouri, M.1    Chen, E.2    Looman, M.3
  • 8
    • 41849095644 scopus 로고    scopus 로고
    • Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study
    • Kriechbaum K, Michels S, Prager F, et al. Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol. 2008;92:518-522.
    • (2008) Br J Ophthalmol , vol.92 , pp. 518-522
    • Kriechbaum, K.1    Michels, S.2    Prager, F.3
  • 9
    • 84862817252 scopus 로고    scopus 로고
    • Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial
    • Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology. 2012;119:802-809.
    • (2012) Ophthalmology , vol.119 , pp. 802-809
    • Heier, J.S.1    Campochiaro, P.A.2    Yau, L.3
  • 10
    • 83455255128 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for treatment of macular edema secondary to central retinal vein occlusion: eighteen-month results of a prospective trial
    • Zhang H, Liu ZL, Sun P, et al. Intravitreal bevacizumab for treatment of macular edema secondary to central retinal vein occlusion: eighteen-month results of a prospective trial. J Ocul Pharmacol Ther. 2011;27:615-621.
    • (2011) J Ocul Pharmacol Ther , vol.27 , pp. 615-621
    • Zhang, H.1    Liu, Z.L.2    Sun, P.3
  • 11
    • 84873738185 scopus 로고    scopus 로고
    • Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study
    • Brown DM, Heier JS, Clark WL, et al. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol. 2013;155:429-437.
    • (2013) Am J Ophthalmol , vol.155 , pp. 429-437
    • Brown, D.M.1    Heier, J.S.2    Clark, W.L.3
  • 12
    • 84926316405 scopus 로고    scopus 로고
    • Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment
    • Song W, Xia X. Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment. BMC Ophthalmol. 2015;15:31.
    • (2015) BMC Ophthalmol , vol.15 , pp. 31
    • Song, W.1    Xia, X.2
  • 13
    • 84885004807 scopus 로고    scopus 로고
    • Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis
    • Lu Y, Su L, Xu X. Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis. J Ocul Pharmacol Ther. 2013;29:702-708.
    • (2013) J Ocul Pharmacol Ther , vol.29 , pp. 702-708
    • Lu, Y.1    Su, L.2    Xu, X.3
  • 14
    • 84928586376 scopus 로고    scopus 로고
    • Comparison of injection of intravitreal drugs with standard care in macular edema secondary to branch retinal vein occlusion
    • Lee K, Jung H, Sohn J. Comparison of injection of intravitreal drugs with standard care in macular edema secondary to branch retinal vein occlusion. Korean J Ophthalmol. 2014;28:19-25.
    • (2014) Korean J Ophthalmol , vol.28 , pp. 19-25
    • Lee, K.1    Jung, H.2    Sohn, J.3
  • 16
    • 85028650281 scopus 로고    scopus 로고
    • 2016. Accessed January 19, 2016
    • ® in Patients With Branch Retinal Vein Occlusion. https://clinicaltrials.gov/ct2/show/NCT01427751?term=NCT01427751&rank=1. 2016. Accessed January 19, 2016.
    • ® in Patients With Branch Retinal Vein Occlusion
  • 17
    • 84924054198 scopus 로고    scopus 로고
    • Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study
    • Campochiaro PA, Clark WL, Boyer DS, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study. Ophthalmology. 2015;122:538-544.
    • (2015) Ophthalmology , vol.122 , pp. 538-544
    • Campochiaro, P.A.1    Clark, W.L.2    Boyer, D.S.3
  • 18
    • 84981325283 scopus 로고    scopus 로고
    • Prospective pilot study: efficacy of intravitreal dexamethasone and bevacizumab injections in the treatment of macular oedema associated with branch retinal vein occlusion
    • Guignier B, Subilia-Guignier A, Fournier I, et al. Prospective pilot study: efficacy of intravitreal dexamethasone and bevacizumab injections in the treatment of macular oedema associated with branch retinal vein occlusion. Ophthalmologica. 2013;230:43-49.
    • (2013) Ophthalmologica , vol.230 , pp. 43-49
    • Guignier, B.1    Subilia-Guignier, A.2    Fournier, I.3
  • 19
    • 84921540400 scopus 로고    scopus 로고
    • Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial
    • Pielen A, Mirshahi A, Feltgen N, et al. Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial. Acta Ophthalmol. 2015;93:e29-e37.
    • (2015) Acta Ophthalmol , vol.93 , pp. e29-e37
    • Pielen, A.1    Mirshahi, A.2    Feltgen, N.3
  • 20
    • 84885944807 scopus 로고    scopus 로고
    • Intravitreal treatment of patients with branch retinal vein occlusion depending on the duration of macular edema [German]
    • Rehak M, Spies E, Scholz M, et al. Intravitreal treatment of patients with branch retinal vein occlusion depending on the duration of macular edema [German]. Der Ophthalmologe. 2013;110:966-974.
    • (2013) Der Ophthalmologe , vol.110 , pp. 966-974
    • Rehak, M.1    Spies, E.2    Scholz, M.3
  • 21
    • 66149138872 scopus 로고    scopus 로고
    • Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion
    • Russo V, Barone A, Conte E, et al. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion. Retina. 2009;29:511-515.
    • (2009) Retina , vol.29 , pp. 511-515
    • Russo, V.1    Barone, A.2    Conte, E.3
  • 22
    • 84890448796 scopus 로고    scopus 로고
    • Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion
    • Tan MH, McAllister IL, Gillies ME, et al. Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion. Am J Ophthalmol. 2014;157:237-247.
    • (2014) Am J Ophthalmol , vol.157 , pp. 237-247
    • Tan, M.H.1    McAllister, I.L.2    Gillies, M.E.3
  • 23
    • 79955552475 scopus 로고    scopus 로고
    • Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion
    • Ding X, Li J, Hu X, et al. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Retina. 2011;31:838-845.
    • (2011) Retina , vol.31 , pp. 838-845
    • Ding, X.1    Li, J.2    Hu, X.3
  • 24
    • 84907906125 scopus 로고    scopus 로고
    • Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison
    • Gado AS, Macky TA. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison. Clin Exp Ophthalmol. 2014;42:650-655.
    • (2014) Clin Exp Ophthalmol , vol.42 , pp. 650-655
    • Gado, A.S.1    Macky, T.A.2
  • 26
    • 84927171164 scopus 로고    scopus 로고
    • Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent onset central retinal vein occlusion
    • Ramezani A, Esfandiari H, Entezari M, et al. Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent onset central retinal vein occlusion. Acta Ophthalmol. 2014;92:e530-e539.
    • (2014) Acta Ophthalmol , vol.92 , pp. e530-e539
    • Ramezani, A.1    Esfandiari, H.2    Entezari, M.3
  • 27
    • 84891626905 scopus 로고    scopus 로고
    • Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO study
    • Korobelnik JF, Holz FG, Roider J, et al. Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO study. Ophthalmology. 2014;121:202-208.
    • (2014) Ophthalmology , vol.121 , pp. 202-208
    • Korobelnik, J.F.1    Holz, F.G.2    Roider, J.3
  • 28
    • 33746509667 scopus 로고    scopus 로고
    • Intraocular pressure alterations following intravitreal triamcinolone acetonide
    • Rhee DJ, Peck RE, Belmont J, et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol. 2006;90:999-1003.
    • (2006) Br J Ophthalmol , vol.90 , pp. 999-1003
    • Rhee, D.J.1    Peck, R.E.2    Belmont, J.3
  • 29
    • 61349134752 scopus 로고    scopus 로고
    • Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection
    • Roth DB, Verma V, Realini T, et al. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection. Ophthalmology. 2009;116:455-460.
    • (2009) Ophthalmology , vol.116 , pp. 455-460
    • Roth, D.B.1    Verma, V.2    Realini, T.3
  • 31
    • 62649161064 scopus 로고    scopus 로고
    • Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab
    • Funk M, Kriechbaum K, Prager F, et al. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci. 2009;50:1025-1032.
    • (2009) Invest Ophthalmol Vis Sci , vol.50 , pp. 1025-1032
    • Funk, M.1    Kriechbaum, K.2    Prager, F.3
  • 32
    • 0027942607 scopus 로고
    • Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
    • Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
    • (1994) N Engl J Med , vol.331 , pp. 1480-1487
    • Aiello, L.P.1    Avery, R.L.2    Arrigg, P.G.3
  • 33
    • 84872021668 scopus 로고    scopus 로고
    • Vascular endothelial growth factor a in intraocular vascular disease
    • Miller JW, Le Couter J, Strauss EC, et al. Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology. 2013;120:106-114.
    • (2013) Ophthalmology , vol.120 , pp. 106-114
    • Miller, J.W.1    Le Couter, J.2    Strauss, E.C.3
  • 34
    • 84864426358 scopus 로고    scopus 로고
    • Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion
    • Azad R, Vivek K, Sharma Y, et al. Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion. Indian J Ophthalmol. 2012;60:263.
    • (2012) Indian J Ophthalmol , vol.60 , pp. 263
    • Azad, R.1    Vivek, K.2    Sharma, Y.3
  • 35
    • 84908689970 scopus 로고    scopus 로고
    • Comparative evaluation between ranibizumab combined with laser and bevacizumab combined with laser versus laser alone for macular oedema secondary to branch retinal vein occlusion
    • Azad SV, Salman A, Mahajan D, et al. Comparative evaluation between ranibizumab combined with laser and bevacizumab combined with laser versus laser alone for macular oedema secondary to branch retinal vein occlusion. Middle East Afr J Ophthalmol. 2014;21:296-301.
    • (2014) Middle East Afr J Ophthalmol , vol.21 , pp. 296-301
    • Azad, S.V.1    Salman, A.2    Mahajan, D.3
  • 36
    • 77957039719 scopus 로고    scopus 로고
    • A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion
    • Çekiç O, Çakır M, Yazıcı AT, et al. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Curr Eye Res. 2010;35:925-929.
    • (2010) Curr Eye Res , vol.35 , pp. 925-929
    • Çekiç, O.1    Çakır, M.2    Yazıcı, A.T.3
  • 37
    • 84906280057 scopus 로고    scopus 로고
    • Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion
    • Fan C, Wang Y, Ji Q, et al. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion. Curr Eye Res. 2014;39:938-943.
    • (2014) Curr Eye Res , vol.39 , pp. 938-943
    • Fan, C.1    Wang, Y.2    Ji, Q.3
  • 38
    • 84982105800 scopus 로고    scopus 로고
    • Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion
    • Moon J, Kim M, Sagong M. Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion. Eye. 2016;30:1084-1090.
    • (2016) Eye , vol.30 , pp. 1084-1090
    • Moon, J.1    Kim, M.2    Sagong, M.3
  • 39
    • 84863730642 scopus 로고    scopus 로고
    • Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion
    • Donati S, Barosi P, Bianchi M, et al. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion. Eur J Ophthalmol. 2011;22:607-614.
    • (2011) Eur J Ophthalmol , vol.22 , pp. 607-614
    • Donati, S.1    Barosi, P.2    Bianchi, M.3
  • 40
    • 0034798467 scopus 로고    scopus 로고
    • The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology
    • Stefánsson E. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand. 2001;79:435-440.
    • (2001) Acta Ophthalmol Scand , vol.79 , pp. 435-440
    • Stefánsson, E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.